Sale clinical research organization (CRO) and statistics company in Germany

• The company sold is a Clinical Research Organization company (CRO) and statistics company located in Germany
• The acquired company has revenues of 1- 2 mio €
• The buyer is a listed CRO and co-development company from the UK
• CFIE business sale input: The CFIE M&A team member helped in achieving a top level valuation for the seller in the form of an share deal and managed the complete selling process

Here you find a description of a business sale of a CRO and statistics company in Germany. The CRO and statistics company is a renowned company focussing on CRO services for the pharmaceutical and medical devices industry. The company faced the problem of not having a suitable successor for the owners to guarantee a long-term perspective for the company and its employees . The CFIE M&A team helped the seller in the business sale to an international buyer. Find more details on the business sale of a CRO and statistics company below.

The listed UK based CRO and co-development company is providing drug development services to the pharmaceutical industry and has a growing portfolio of co-development partnerships. It operates in over 50 countries.

Both of these bolt-on acquisitions are in line with the strategy that was laid out at the buyer’s IPO for augmenting the growth of the buyer’s services businesses. It increases the acquirer’s footprint in Germany significantly. The German CRO and statistics company add significant, tangible value including a proprietary Electronic Data Capture system, which will be developed further especially in the area of post-marketing data collection.

Founded in 1991, the seller is a full service contract research organisation (CRO) offering services from Phase II through to Phase IV clinical studies, as well as non-interventional and health-economic studies for the pharmaceutical and medical device industries. In its 25 year history, the company has worked on more than 150 assignments for more than 60 clients. To support its clinical offering, since 1998 it has developed and uses a proprietary FDA validated Electronic Data Capture (‘EDC’) system, which can be configured for individual trials on a multilingual basis.

It also offers data management, statistical analysis, biometric reporting and statistical consulting services for the pharmaceutical industry. In total, the seller has undertaken more than 180 assignments in all phases of clinical research for over 50 clients.

The seller enjoys a strong brand awareness in their home markets and will complement buyer’s existing European CRO network. Also, it will significantly enhance buyer’s in-house capabilities and will become the centre of excellence for data management and statistics for the buyer worldwide.

Frits Verheesen helped the seller in preparing the relevant business sale documentation and in the valuation of the company. It worked out a plan and strategy to achieve the highest sales price for the seller. An overview was made which buyers to speak to and how to structure the sales process. Frits Verheesen helped in approaching the right buyer and brought them together. Both companies realized the benefits of the combination. Frits Verheesen helped the seller in negotiating a good agreement which ended in an M&A transaction in form of an share deal between the companies.

Feel free to contact us for further details about this business sale in Germany. If you are looking for acquisitions or business sales of service companies in other countries than Germany it is also good to contact us. We know other available targets as well as investors/buyers in Europe or would be able to find the ones that suit you.